NCT01419392

Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages

Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages: a Randomized Clinical Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Ain Shams University · Academic / Other
• Sex: Female
• Age: 18 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether sildenafil citrate is effective in improving uterine artery blood flow and oxidative stress in patients with unexplained recurrent miscarriages

Conditions

• Recurrent Miscarriage

Interventions

Type	Name	Description
DRUG	Sildenafil citrate	25 mg orally, 4 times per day for 21 days
DRUG	matching placebo	orally, 4 times per day for 21 days

Timeline

• Start date: 2011-09-01
• Primary completion: 2012-04-01
• Completion: 2012-06-01
• First posted: 2011-08-18
• Last updated: 2012-04-17

Locations

1 site across 1 country: Egypt